Warburg, Novo Plan to Sell Archimedes Pharma

U.S. buyout firm and Danish investor eye an exit

By

Amy Or

May 12, 2014 8:08 p.m. GMT

Warburg Pincus and Danish investment firm Novo AS are looking to sell Archimedes Pharma Ltd., a U.K. specialty pharmaceutical company in a deal that may fetch up more than $200 million, said three people familiar with the situation.

Two of the people said Reading, England-based Archimedes, which has a portfolio of specialty products focused on the oncology, pain and critical-care sectors throughout Europe, is expected to post $74 million in revenue this year. One of them said strategics are likely to be the buyer of the asset...